No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use
-
Canada / epidemiology
-
Diabetes Mellitus, Type 1 / complications
-
Diabetes Mellitus, Type 2 / complications
-
Diabetic Retinopathy / diagnosis*
-
Diabetic Retinopathy / epidemiology
-
Diabetic Retinopathy / therapy*
-
Evidence-Based Medicine*
-
Humans
-
Incidence
-
Laser Coagulation
-
Ophthalmology / organization & administration*
-
Prevalence
-
Societies, Medical*
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Vitrectomy
Substances
-
Angiogenesis Inhibitors
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A